Viewing Study NCT00689403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2025-12-26 @ 10:59 PM
Study NCT ID: NCT00689403
Status: COMPLETED
Last Update Posted: 2010-12-03
First Post: 2008-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD1305 View
None pharmacokinetics View
None Properties of different ER formulations View